Moteur de recherche d’entreprises européennes
Financement de l’UE (4 264 953 €) : Transfert de surface d’agents pathogènes Hor 29/07/2022 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Transfert de surface d’agents pathogènes
The STOP project will develop antimicrobial and antiviral nanocoatings that can be flexibly or permanently applied to high-touch surfaces. These nanocoatings will be derived from a combination of inorganic nanoparticles, antimicrobial peptides and nanoscale laser surface patterning. The nanocoatings will be thoroughly characterised for their efficacy, using both existing international standards and improved testing methods developed within the project (the new testing methods will be proposed to standards agencies for adoption). Several different active substances will be explored (i) to allow formulation in highly flexible, sprayable, and long-lasting coatings, (ii) provide broad spectrum antimicrobial antiviral activity, and iii) reduce the chances of the development of resistance. To this end, the mode-of-action, and the risk of selection for antimicrobial resistance in bacteria and viruses will be assessed. The flexible nanocoatings will provide a long-lasting (30 days) reduction in bioburden that resembles standards set for microbial colonization of surfaces in hospitals, which can only be reached after intense surface disinfection or permanent introduction of known antimicrobial material such as copper. This effect will be studied in a real-life intervention trail and with epidemiological models. The developed nanocoatings are expected to lead to significant reductions in infectious diseases transmitted from high-touch surfaces, healthcare cost savings, reduction in environmental pollution by disinfectants, and increased preparedness of the EU public health system to future pandemics. The safety of the nanomaterials will be backed up by human and environmental toxicity studies and life cycle analyses. From the beginning, attention will be paid to end-user acceptance, manufacturing scalability, and short-term exploitation by SMEs
| Amanuensis GmbH | ? |
| Affix Labs Oy | 337 250 € |
| Apel Laser Srl | 332 500 € |
| Astiki Mi Kerdoskopiki Etaireia Proliptikis Perivallontikis Kai Ergasiakis Iatrikis | 207 250 € |
| Bundesanstalt Fuer Materialforschung UND -Pruefung | 1 062 384 € |
| Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. | 234 518 € |
| Idryma Technologias Kai Erevnas | 552 246 € |
| Institut Pro Elektronika NA Ban - Institute OF Electronics Bulgarian Academy OF Sciences | 285 000 € |
| Ruder Boskovic Institute | 285 030 € |
| Satakunnan Ammattikorkeakoulu Oy | 284 905 € |
| Tartu Ulikool | 399 950 € |
| Universita Degli Studi Di Trieste | 283 920 € |
https://cordis.europa.eu/project/id/101057961
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Amanuensis Sàrl, Toffen, Suisse.
